ロード中...

Proton Pump Inhibitor Prescribing Patterns in Newborns and Infants

OBJECTIVES: In 2011, the Food and Drug Administration (FDA) approved intravenous esomeprazole 0.5 mg/day for children aged >1 month and oral esomeprazole for infants aged 1 month to <1 year at doses of 2.5, 5, and 10 mg based on weight. Prior to 2011, proton pump inhibitors (PPIs) were not app...

詳細記述

保存先:
書誌詳細
出版年:J Pediatr Pharmacol Ther
主要な著者: Illueca, Marta, Alemayehu, Berhanu, Shoetan, Nze, Yang, Huiying
フォーマット: Artigo
言語:Inglês
出版事項: Pediatric Pharmacy Advocacy Group 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4341413/
https://ncbi.nlm.nih.gov/pubmed/25762873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-19.4.283
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!